PDF herunterladen
Thromb Haemost 2006; 96(06): 855-856
DOI: 10.1160/TH06-09-0537
Letters to the Editor
Schattauer GmbH

Classification of patients with antiphospholipid syndrome into risk categories: An evolving process

Vittorio Pengo
1   Clinical Cardiology, Thrombosis Center, Department of Cardiac Thoracic and Vascular Sciences, University of Padova, Padova, Italy
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 25. September 2006

Accepted after revision 02. November 2006

Publikationsdatum:
29. November 2017 (online)

Auch verfügbar auf
    Lizenzen und Reprints

 

 

  • References

  • 1 Wilson WA, Gharavi AE, Koike T. et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum 1999; 42: 1309-11.
    CrossrefPubMedSuche in Google Scholar
  • 2 Miyakis S, Lockshin MD, Atsumi T. et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 04: 295-306.
    CrossrefPubMedSuche in Google Scholar
  • 3 Detkova D, Gil-Aguado A, Lavilla P. et al. Do antibodies to beta2-glycoprotein 1 contribute to the better characterization of the antiphospholipid syndrome?. Lupus 1999; 08: 430-8.
    CrossrefPubMedSuche in Google Scholar
  • 4 Lee EY, Lee CK, Lee TH. et al. Does the antibeta2-glycoprotein I antibody provide additional information in patients with thrombosis?. Thromb Res 2003; 111: 29-32.
    CrossrefPubMedSuche in Google Scholar
  • 5 Pengo V, Biasiolo A, Pegoraro C. et al. Antibody profiles for the diagnosis of antiphospholipid syndrome. Thromb Haemost 2005; 93: 1147-52.
    Thieme ConnectPubMedSuche in Google Scholar
  • 6 Sailer T, Zoghlami C, Kurz C. et al. Anti-beta2-glycoprotein I antibodies are associated with pregnancy loss in women with the lupus anticoagulant. Thromb Haemost 2006; 95: 796-801.
    Thieme ConnectPubMedSuche in Google Scholar
  • 7 Zoghlami-Rintelen C, Vormittag R, Sailer T. et al. The presence of IgG antibodies against beta2-glycoproteinI predicts the risk of thrombosis in patients with the lupus anticoagulant. J Thromb Haemost 2005; 03: 1160-5.
    CrossrefPubMedSuche in Google Scholar
  • 8 de Laat HB, Derksen RH, Urbanus RT. et al. Beta2-glycoprotein I dependent lupus anticoagulant highly correlates with thrombosis in the Antiphospholipid Syndrome. Blood 2004; 104: 3598-602.
    CrossrefPubMedSuche in Google Scholar
  • 9 de Laat B, Derksen RH, Urbanus RT. et al. IgG antibodies that recognize epitope Gly40-Arg43 in domainI of β2-glycoproteinI cause LAC and their presence correlates strongly with thrombosis. Blood 2005; 105: 1540-5.
    CrossrefPubMedSuche in Google Scholar
  • 10 Galli M, Luciani D, Bertolini G. et al. Lupus Anticoagulants are stronger risk factors of thrombosis than anticardiolipin antibodies: a systematic review of the literature. Blood 2003; 101: 1827-32.
    CrossrefPubMedSuche in Google Scholar
  • 11 Galli M, Luciani D, Bertolini G. et al. Anti-β2-GlycoproteinI antibodies, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid sindrome. Blood 2003; 102: 2717-23.
    CrossrefPubMedSuche in Google Scholar
  • 12 Ruffatti A, Tonello M, Del Ross T. et al. Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity. Thromb Hamost 2006; 96: 337-41.
    PubMedSuche in Google Scholar